Haleon PLC Sponsored ADR (NYSE:HLN) Short Interest Up 31.6% in December

Haleon PLC Sponsored ADR (NYSE:HLN) was the target of a large increase in short interest in the month of December. As of December 31st, there was short interest totaling 18,869,983 shares, an increase of 31.6% from the December 15th total of 14,336,665 shares. Approximately 0.4% of the company’s shares are short sold. Based on an average daily volume of 8,781,092 shares, the days-to-cover ratio is presently 2.1 days. Based on an average daily volume of 8,781,092 shares, the days-to-cover ratio is presently 2.1 days. Approximately 0.4% of the company’s shares are short sold.

Wall Street Analysts Forecast Growth

HLN has been the topic of a number of research analyst reports. Deutsche Bank Aktiengesellschaft downgraded Haleon from a “hold” rating to a “sell” rating in a report on Monday, January 12th. Morgan Stanley reaffirmed an “overweight” rating on shares of Haleon in a research report on Monday, December 15th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Haleon in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, four have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Haleon presently has a consensus rating of “Hold” and an average target price of $12.33.

Institutional Investors Weigh In On Haleon

A number of hedge funds have recently made changes to their positions in HLN. Perigon Wealth Management LLC bought a new stake in Haleon in the 4th quarter worth approximately $108,000. Blue Trust Inc. raised its holdings in Haleon by 48.6% during the 4th quarter. Blue Trust Inc. now owns 81,731 shares of the company’s stock valued at $826,000 after buying an additional 26,731 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management lifted its position in Haleon by 375.8% in the fourth quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 54,429 shares of the company’s stock worth $550,000 after buying an additional 42,989 shares during the last quarter. Scharf Investments LLC increased its position in Haleon by 17.4% during the fourth quarter. Scharf Investments LLC now owns 1,095,734 shares of the company’s stock valued at $11,078,000 after acquiring an additional 162,406 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC boosted its stake in shares of Haleon by 49.8% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 38,484 shares of the company’s stock worth $387,000 after purchasing an additional 12,793 shares during the period. 6.67% of the stock is currently owned by hedge funds and other institutional investors.

Haleon Price Performance

HLN traded up $0.07 on Monday, hitting $9.84. 6,653,058 shares of the company’s stock traded hands, compared to its average volume of 7,338,229. Haleon has a one year low of $8.71 and a one year high of $11.42. The company has a current ratio of 0.87, a quick ratio of 0.63 and a debt-to-equity ratio of 0.48. The firm has a market cap of $43.82 billion, a price-to-earnings ratio of 25.23 and a beta of 0.19. The company’s 50 day simple moving average is $9.81 and its 200-day simple moving average is $9.60.

About Haleon

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.